Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales... Show more
ONC is expected to report earnings to fall 69.89% to -43 cents per share on May 01
Q1'25
Est.
$-0.43
Q4'24
Missed
by $0.42
Q3'24
Beat
by $0.95
The last earnings report on February 27 showed earnings per share of -142 cents, missing the estimate of -100 cents. With 519.87K shares outstanding, the current market capitalization sits at 26.88B.